gemcitabine has been researched along with alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chow, KU; Hoelzer, D; Kim, SZ; Kriener, S; Mitrou, PS; Schui, DK; Sterry, W; Weidmann, E; Zollner, TM | 1 |
1 review(s) available for gemcitabine and alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc
Article | Year |
---|---|
CD4+ CD56+ neoplasia: clinical and biological features with emphasis on cytotoxic drug-induced apoptosis and expression of sialyl Lewis X.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; CD4 Antigens; CD56 Antigen; Cladribine; Deoxycytidine; Drug Synergism; Female; Gemcitabine; Hematologic Neoplasms; Humans; Immunophenotyping; Lewis X Antigen; Oligosaccharides; Sialyl Lewis X Antigen | 2003 |